BM
PRME icon

Brandywine Managers’s Prime Medicine PRME Stock Holding History

Brandywine Managers’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-32,977
Closed -$231K – 40
2024
Q1 		$231K Hold
32,977
– – 0.23% 38
2023
Q4 		$292K Hold
32,977
– – 0.32% 36
2023
Q3 		$315K Hold
32,977
– – 0.53% 30
2023
Q2 		$483K Hold
32,977
– – 0.32% 35
2023
Q1 		$406K Hold
32,977
– – 0.29% 36
2022
Q4 		$613K Buy
+32,977
New +$596K 2.14% 14

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Brandywine Managers's PRME Position: Q2 2024 in Review

Brandywine Managers sold out of Prime Medicine (PRME) in Q2 2024, closing a stake of 32,977 shares — an estimated $231K sold.

Brandywine Managers first reported a position in PRME in Q4 2022 and held it in 6 quarters. The position peaked at $613K in Q4 2022. 122 funds tracked by Wall St. Rank hold PRME as of Q2 2024.

  • Brandywine Managers reported no remaining Prime Medicine position as of Q2 2024 after selling out during the quarter.
  • Brandywine Managers sold 32,977 Prime Medicine shares in Q2 2024, an estimated $231K.
  • Brandywine Managers first reported a position in Prime Medicine in Q4 2022 and held it in 6 quarters.
  • Brandywine Managers's Prime Medicine position peaked at $613K in Q4 2022.
  • 122 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2024.

Based on Brandywine Managers's 13F filing for Q2 2024, filed 14 Aug 2024.